I really dont care what you believe. When VP's and Medical Directors of Pharma companies who focus in oncology tell me things I listen. I think they understand how things are done and if you think that Genta didnt everything by the book and the people at Genta are so smart why is their stock at a penny and they have no money. Why has the FDA asked them over and over to confirm the original findings?? Read this article http://www.bio-itworld.com/archive/061704/genasense
This is when Genta actually had money. I'm sure you will see some lines in the article such as
critical weaknesses in how the Phase III trial data were analyzed
Pivotal data from the Phase III trial “could be falsely positive,” the reviewers wrote.
but there are important issues of statistical integrity
When you have a clue to what your talking about get back to me.